HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells
Although human induced pluripotent stem cells (iPSCs) can serve as a universal cell source for regenerative medicine, the use of iPSCs in clinical applications is limited by prohibitive costs and prolonged generation time. Moreover, allogeneic iPSC transplantation requires preclusion of mismatches b...
Main Authors: | Yoo-Wook Kwon, Hyo-Suk Ahn, Jin-Woo Lee, Han-Mo Yang, Hyun-Jai Cho, Seok Joong Kim, Shin-Hyae Lee, Heung-Mo Yang, Hyun-Duk Jang, Sung Joo Kim, Hyo-Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/8873383 |
Similar Items
-
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
by: Yi Yang, et al.
Published: (2018-01-01) -
Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
by: Eunhye Kim, et al.
Published: (2016-09-01) -
Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-01-01) -
Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-07-01) -
Elimination of Mutant mtDNA by an Optimized mpTALEN Restores Differentiation Capacities of Heteroplasmic MELAS-iPSCs
by: Naoki Yahata, et al.
Published: (2021-03-01)